CD33-directed Cytotoxin

Accession Number

DBCAT003264

Description

Not Available

Drugs

Drug	Drug Description
Gemtuzumab ozogamicin	A monoclonal anti-CD33 antibody used to treat CD33-positive acute myeloid leukemia.

Drugs & Drug Targets

Drug	Target	Type
Gemtuzumab ozogamicin	Myeloid cell surface antigen CD33	target
Gemtuzumab ozogamicin	Low affinity immunoglobulin gamma Fc region receptor III-B	target
Gemtuzumab ozogamicin	Low affinity immunoglobulin gamma Fc region receptor III-A	target
Gemtuzumab ozogamicin	High affinity immunoglobulin gamma Fc receptor I	target